Skip to main content

Table 3 Surgical procedure and pathological findings

From: Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

 

n

%

Surgery

  

  Anterior resection

28

36.8%

  Abdominal perineal resection

46

60.5%

  Hartmann

2

2.6%

Lymphatic or vascular invasion

  

  No

71

93.4%

  Yes

5

6.6%

Neural invasion

  

  No

68

89.5%

  Yes

8

10.5%

CRM

  

  Negative

76

100.0%

  Positive

0

0.0%

ypT stage

  

  T0

18

23.7%

  T1

10

13.2%

  T2

20

26.3%

  T3

26

34.2%

  T4

2

2.6%

ypN stage

  

  N0

47

61.8%

  N1

19

25.0%

  N2

10

13.2%

Examined lymph nodes

  

  Median (Min-max)

12(2–35)

TRG Score

  

  4

18

23.1%

  3

34

43.6%

  2

17

21.8%

  1

7

9.0%

Total

76

100.0%

  1. CRM: circumferential resection margin.
  2. TRG: tumor regression grade.